Cixutumumab (Anti-IGF1R / CD221)
Product Specifications
CAS Number
947687-12-9
Synonyms
IMC-A12
SKU
C00385-1mg
Additionnal Information
Cixutumumab (Anti-IGF1R / CD221) is a humanized monoclonal antibody with high affinity that targets type-1-insulin-like growth factor receptor (IGF-1R) .It shows broad-spectrum anti-tumour activity and can be used in studies of sarcomas, neuroblastoma, wilms tumor, lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer. MW :150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1410443-01 0.02 mg (E-Coli)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details 
MBS1410443-02 0.1 mg (E-Coli)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details 
MBS1410443-03 0.02 mg (Yeast)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details 
MBS1410443-04 0.1 mg (Yeast)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details MBS1410443-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details MBS1410443-06 0.02 mg (Mammalian-Cell)
Recombinant Staphylococcus haemolyticus Probable nicotinate-nucleotide adenylyltransferase (nadD)
Sign In for Pricing
View Details